Health
With demand uncertain and its U.S. manufacturing in limbo, AstraZeneca still aims to seek FDA nod for COVID-19 vaccine – FiercePharma
AstraZeneca’s target window to apply for emergency use authorization of its troubled COVID-19 vaccine in the U.S. has passed. But the company still plans to seek…
Its COVID-19 vaccine has been vilified and its manufacturing network has been questioned, but AstraZeneca is still planning to apply for emergency use authorization of its shot in the U.S., a company spokesman confirmed.
A month ago, after AZ said its vaccine succeeded in phase 3 testing, an AstraZeneca executive said the company would apply for an emergency nod in America in the first half of April.
Assuming that the approval will take place in a fast way, we hope to deliver 30 million doses instantly,…
-
General23 hours agoDairy farmers devastated by floods across parts of New South Wales
-
Noosa News20 hours agoBrisbane’s Triffid forces redesign of $1.5 billion tower project
-
Noosa News23 hours agoMan dies in Gold Coast after rolling trailer pins him to lamp-post
-
General16 hours agoIsraeli forces open fire towards diplomatic delegation touring Jenin in the northern West Bank